白内障及复杂眼手术后炎症管理:系统综述与德尔菲调查
系统综述发现,白内障术后炎症管理中,奈帕芬酸、酮咯酸、溴芬酸、氯替泼诺和地氟泼尼特分别在三项、一项、七项、三项和六项随机对照试验中均显示阳性结果,而氟比洛芬在一项试验中未显示阳性结果。28名国际专家参与的德尔菲调查将小梁切除术、视网膜脱离手术和联合超声乳化玻璃体切除术评为比白内障手术更具炎症性,针对小梁切除术专家组倾向于比白内障手术更长的治疗时间(非甾体抗炎药+皮质类固醇每日三次,持续2个月 vs 1个月)。
要点
- 白内障术后炎症管理中,奈帕芬酸(3/3)、酮咯酸(1/1)、溴芬酸(7/7)、氯替泼诺(3/3)和地氟泼尼特(6/6)在各自随机对照试验中均显示阳性结果,氟比洛芬(0/1)未显示阳性结果。
- 德尔菲专家组将小梁切除术、视网膜脱离手术和联合超声乳化玻璃体切除术评为比白内障手术更具炎症性,而黄斑裂孔或视网膜前膜玻璃体切除术未被评定为比白内障手术更具炎症性。
- 专家组对小梁切除术倾向于比白内障手术更长的治疗(非甾体抗炎药+皮质类固醇每日三次,持续2个月 vs 1个月),对单纯玻璃体切除术、视网膜脱离手术和联合超声乳化玻璃体切除术倾向于与白内障手术相同的治疗(非甾体抗炎药+皮质类固醇每日三次,持续1个月)。
主要发现
- 白内障术后炎症管理中,奈帕芬酸在3/3项随机对照试验中产生阳性结果,酮咯酸1/1、溴芬酸7/7、氯替泼诺3/3、地氟泼尼特6/6均产生阳性结果,而氟比洛芬0/1未产生阳性结果。
- 单项研究发现倍他米松在视网膜脱离手术后结果不确定;酮咯酸在玻璃体切除术后有效(1/1),而曲安奈德在小梁切除术后无效(0/1)。
- 专家组将小梁切除术、视网膜脱离手术和联合超声乳化玻璃体切除术评为比白内障手术更具炎症性。
- 黄斑裂孔或视网膜前膜玻璃体切除术未被评定为比白内障手术更具炎症性。
- 对小梁切除术,专家组倾向于比白内障手术更长的治疗(非甾体抗炎药+皮质类固醇每日三次,持续2个月 vs 1个月);对单纯玻璃体切除术、视网膜脱离手术和联合超声乳化玻璃体切除术,倾向于与白内障手术相同的治疗(非甾体抗炎药+皮质类固醇每日三次,持续1个月)。
关键数值与推荐
- 白内障术后炎症管理:奈帕芬酸3/3项随机对照试验阳性,酮咯酸1/1阳性,溴芬酸7/7阳性,氯替泼诺3/3阳性,地氟泼尼特6/6阳性,氟比洛芬0/1阳性。
- 视网膜脱离手术后:倍他米松结果不确定(单项研究)。
- 玻璃体切除术后:酮咯酸有效(1/1)。
- 小梁切除术后:曲安奈德无效(0/1)。
- 德尔菲专家组对小梁切除术首选非甾体抗炎药+皮质类固醇每日三次持续2个月,对单纯玻璃体切除术、视网膜脱离手术和联合超声乳化玻璃体切除术首选非甾体抗炎药+皮质类固醇每日三次持续1个月。
临床怎么用
- 专家组倾向于对小梁切除术使用非甾体抗炎药+皮质类固醇每日三次持续2个月。
- 专家组倾向于对单纯玻璃体切除术、视网膜脱离手术和联合超声乳化玻璃体切除术使用非甾体抗炎药+皮质类固醇每日三次持续1个月。
- 专家组将小梁切除术、视网膜脱离手术和联合超声乳化玻璃体切除术评为比白内障手术更具炎症性,而黄斑裂孔或视网膜前膜玻璃体切除术未被评定为比白内障手术更具炎症性。
局限性
- 原文指出,视网膜脱离和联合玻璃体视网膜手术中首选治疗与专家对眼炎症状态感知之间的差异,凸显了需要随机对照试验来建立治疗指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prevention and management of postoperative ocular inflammation with corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) have been evaluated in several randomised controlled trials (RCTs). However, neither consensus regarding the efficacies of different regimens nor established guidelines are currently available. This has resulted in different practice patterns throughout the world. A systematic literature review found that for the management of postcataract inflammation nepafenac produced a positive outcome in three of three RCTs (3/3), as did ketorolac (1/1), bromfenac (7/7), loteprednol (3/3) and difluprednate (6/6), but not flurbiprofen (0/1). A single study found that betamethasone produced inconclusive results after retinal detachment (RD) surgery; ketorolac was effective (1/1) after vitrectomy, but triamcinolone was ineffective (0/1) after trabeculectomy. A two-round Delphi survey asked 28 international experts to rate both the inflammatory potential of different eye surgeries and their agreement with different treatment protocols. They rated trabeculectomy, RD surgery and combined phacovitrectomy as more inflammatory than cataract surgery. Vitrectomies for macular hole or epiretinal membrane were not deemed more inflammatory than cataract surgery. For trabeculectomy, they preferred to treat longer than for cataract surgery (NSAID + corticosteroid three times a day for 2 months vs 1 month). For vitrectomy alone, RD surgery and combined phacovitrectomy, the panel preferred the same treatment as for cataract surgery (NSAID + corticosteroid three times a day for 1 month). The discrepancy between preferred treatment and perception of the eye's inflammatory status by the experts for RD and combined vitreoretinal surgeries highlights the need for RCTs to establish treatment guidelines.
引用
- Aptel F, Colin C, Kaderli S, et al. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017. PMID: 28774934. doi:10.1136/bjophthalmol-2017-310324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。